The Chairman's small open-market buy signals continued alignment but is not a material catalyst. Monitor for any future escalation in stake or strategic demands, as the activist posture remains unchanged.
Price Chart
Executive Summary
Chairman Choo Chee Kong filed an amended Schedule 13D disclosing open-market purchases of 62,000 ordinary shares of CytoMed Therapeutics between October 5-8, 2026, for ~$60,554. His beneficial ownership increased to 2,974,746 shares (24.92% of outstanding). The filing reflects a modest insider accumulation by the Chairman, with no change in stated purpose or demands.
Key Financial Metrics
Key Facts
- Choo Chee Kong acquired 62,000 ordinary shares in open-market purchases from October 5-8, 2026, for an aggregate ~$60,554.
- Post-acquisition, beneficial ownership stands at 2,974,746 shares, representing 24.92% of 11,934,908 outstanding shares.
- Purchases were made at weighted average prices ranging from $0.9132 to $0.9899 per share.
- No new demands, plans, or proposals were disclosed; the purpose remains investment with potential board-level discussions.
Financial Impact
Approximately $60,554 in open-market purchases, increasing Chairman's stake by ~0.5 percentage points.
Risk Factors
- Low trading volume could amplify price impact of future insider transactions.
- No change in activist demands suggests no near-term catalyst for share price movement.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001493152-26-046685 |
| Document: 0001493152-26-046685-index.html | 0001493152-26-046685 |
| Document: 0001493152-26-046685.txt | 0001493152-26-046685 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | SC 13G/A | $0.9190 $0.9262 | ▲ +0.78% | ▲ +0.07% | $0.9260 (+0.76%) |
Oct 16, 2026 11d ago | SC 13D/A | $0.8799 $0.8520 | ▼ −3.17% | ▼ −3.59% | $0.9260 (+5.24%) |
Oct 13, 2026 14d ago | SC 13D/A | $0.8700 $0.8599 | ▼ −1.16% | ▼ −0.08% | $0.9260 (+6.44%) |
Oct 9, 2026 18d ago | 6-K | $0.8114 $0.8700 | ▼ −7.22% | ▼ −7.23% | $0.9260 (−14.12%) |
Sep 30, 2026 27d ago | 6-K | $0.8430 $0.8999 | ▼ −6.75% | ▼ −6.57% | $0.9260 (−9.85%) |
May 15, 2026 23w ago | 6-K | $1.16 $1.21 | ▲ +4.31% | ▲ +4.37% | $0.9260 (−20.17%) |
May 11, 2026 24w ago | 6-K | $0.8090 $0.7690 | ▼ −4.94% | ▼ −4.81% | $0.9260 (+14.46%) |
Mar 31, 2026 30w ago | 6-K | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.9260 (−7.40%) |
Mar 31, 2026 30w ago | 20-F | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.9260 (−7.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers